211 related articles for article (PubMed ID: 19727011)
1. Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel.
Mora J; Cruz CO; Parareda A; de Torres C
J Pediatr Hematol Oncol; 2009 Oct; 31(10):723-9. PubMed ID: 19727011
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas.
Rapkin L; Qayed M; Brill P; Martin M; Clark D; George BA; Olson TA; Wasilewski-Masker K; Alazraki A; Katzenstein HM
Pediatr Blood Cancer; 2012 Nov; 59(5):854-8. PubMed ID: 22302783
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience.
Kuo C; Kent PM; Logan AD; Tamulonis KB; Dalton KL; Batus M; Fernandez K; Mcfall RE
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221727
[TBL] [Abstract][Full Text] [Related]
4. Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma.
Navid F; Willert JR; McCarville MB; Furman W; Watkins A; Roberts W; Daw NC
Cancer; 2008 Jul; 113(2):419-25. PubMed ID: 18484657
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and safety of fixed dose rate gemcitabine infusion in combination with docetaxel in patients with relapsed/refractory soft tissue sarcoma].
Yao Z; Yang S; Zhao Y; Yao S; Guo H; Liu Y
Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):541-5. PubMed ID: 25327662
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.
Fox E; Patel S; Wathen JK; Schuetze S; Chawla S; Harmon D; Reinke D; Chugh R; Benjamin RS; Helman LJ
Oncologist; 2012; 17(3):321. PubMed ID: 22363068
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcoma.
Kaya AO; Büyükberber S; Ozkan M; Alkiş N; Sevinc A; Ozdemir NY; Alici S; Esbah O; Berk V; Camci C; Ulas A; Coskun U; Benekli M;
Asian Pac J Cancer Prev; 2012; 13(2):463-7. PubMed ID: 22524807
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine/nab-paclitaxel for pediatric relapsed/refractory sarcomas.
Metts JL; Alazraki AL; Clark D; Amankwah EK; Wasilewski-Masker KJ; George BA; Olson TA; Cash T
Pediatr Blood Cancer; 2018 Sep; 65(9):e27246. PubMed ID: 29770997
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine, docetaxel, and bevacizumab in relapsed and refractory pediatric sarcomas.
Hingorani P; Eshun F; White-Collins A; Watanabe M
J Pediatr Hematol Oncol; 2012 Oct; 34(7):524-7. PubMed ID: 23007339
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.
Qi WX; He AN; Tang LN; Shen Z; Lin F; Yao Y
Jpn J Clin Oncol; 2012 May; 42(5):427-31. PubMed ID: 22450929
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma.
Lee EM; Rha SY; Lee J; Park KH; Ahn JH
Cancer Chemother Pharmacol; 2012 Mar; 69(3):635-42. PubMed ID: 21959979
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone.
Palmerini E; Jones RL; Marchesi E; Paioli A; Cesari M; Longhi A; Meazza C; Coccoli L; Fagioli F; Asaftei S; Grignani G; Tamburini A; Pollack SM; Picci P; Ferrari S
BMC Cancer; 2016 Apr; 16():280. PubMed ID: 27098543
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
Seddon B; Strauss SJ; Whelan J; Leahy M; Woll PJ; Cowie F; Rothermundt C; Wood Z; Benson C; Ali N; Marples M; Veal GJ; Jamieson D; Küver K; Tirabosco R; Forsyth S; Nash S; Dehbi HM; Beare S
Lancet Oncol; 2017 Oct; 18(10):1397-1410. PubMed ID: 28882536
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine and docetaxel for the treatment of children and adolescents with recurrent or refractory osteosarcoma: Korea Cancer Center Hospital experience.
Song BS; Seo J; Kim DH; Lim JS; Yoo JY; Lee JA
Pediatr Blood Cancer; 2014 Aug; 61(8):1376-81. PubMed ID: 24692087
[TBL] [Abstract][Full Text] [Related]
15. GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS).
Mora J; Castañeda A; Perez-Jaume S; Lopez-Pousa A; Maradiegue E; Valverde C; Martin-Broto J; Garcia Del Muro X; Cruz O; Cruz J; Martinez-Trufero J; Maurel J; Vaz MA; de Alava E; de Torres C
Br J Cancer; 2017 Sep; 117(6):767-774. PubMed ID: 28787430
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma.
Tansir G; Rastogi S; Kumar A; Barwad A; Mridha AR; Dhamija E; Shamim SA; Bhatnagar S; Bhoriwal S
BMC Cancer; 2023 Jul; 23(1):639. PubMed ID: 37422615
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.
He A; Qi W; Huang Y; Sun Y; Shen Z; Zhao H; Yang Y; Yao Y
Int J Clin Oncol; 2013 Jun; 18(3):498-505. PubMed ID: 22534798
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel and gemcitabine in the treatment of soft tissue sarcoma - a single-center experience.
Ebeling P; Eisele L; Schuett P; Bauer S; Schuette J; Moritz T; Seeber S; Flasshove M
Onkologie; 2008 Feb; 31(1-2):11-6. PubMed ID: 18268394
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study.
Hara H; Kawamoto T; Fukase N; Kawakami Y; Takemori T; Fujiwara S; Kitayama K; Nishida K; Kuroda R; Akisue T
BMC Cancer; 2019 Jul; 19(1):725. PubMed ID: 31337342
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].
Maki RG; Wathen JK; Patel SR; Priebat DA; Okuno SH; Samuels B; Fanucchi M; Harmon DC; Schuetze SM; Reinke D; Thall PF; Benjamin RS; Baker LH; Hensley ML
J Clin Oncol; 2007 Jul; 25(19):2755-63. PubMed ID: 17602081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
